Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06263023 · ClinicalTrials.gov registry record
A Central Preservation and Assessment Service to Optimize Donor Kidney Allocation
A clinical trial of Organ Preservation, sponsored by 34 Lives, PBC.
- Active
- Registry status
- 80
- Enrollment target
- 8
- Study locations
NCT06263023: Active study of Organ Preservation, sponsored by 34 Lives, PBC.
NCT06263023 is a study of Organ Preservation that is active but no longer recruiting, run by 34 Lives, PBC. The registered enrollment target is 80 participants. The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06263023, a study of Organ Preservation, is active but no longer recruiting, sponsored by 34 Lives, PBC.
- ACTIVE NOT RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a study to collect information to assess if transporting hard-to-place (HTP) donor kidneys to a central preservation and assessment facility with dedicated organ assessment capabilities increases allocation success to transplant hospitals.
Primary Outcome
The primary objective for this study is a 50% success rate or higher for allocation of Hard-to-Place (HTP) kidneys to a participating transplant center after sNMP assessment at the Sponsor's central facility.
Conditions Studied
Interventions
- OTHER Sub-Normothermic Machine Preservation and Assessment
Study Locations (8)
New York
- Erie County Medical Center - Buffalo
- New York University Langone - New York
- The Mount Sinai Hospital - New York
Illinois
- Edward Hines, Jr. VA Hospital - Chicago
Indiana
- Indiana University Health - Indianapolis
Missouri
- Barnes-Jewish Hospital - St Louis
North Carolina
- Duke University - Durham
Wisconsin
- University of Wisconsin School of Medicine and Public Health - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-04-19 |
| Est. Completion | 2028-03-25 |
What the registry record for NCT06263023 still lists
NCT06263023 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 1 condition, with Organ Preservation appearing as the primary indexed condition, and to 1 intervention - of which Sub-Normothermic Machine Preservation and Assessment is the first listed.
NCT06263023 lists 8 locations in 6 states (New York, Illinois, Indiana).
Frequently Asked Questions
What is clinical trial NCT06263023 about?
NCT06263023 is a clinical study titled "A Central Preservation and Assessment Service to Optimize Donor Kidney Allocation". This is a study to collect information to assess if transporting hard-to-place (HTP) donor kidneys to a central preservation and assessment facility with dedicated organ assessment capabilities increases allocation success to transplant hospitals.
What is the current status of trial NCT06263023?
This trial is currently active not recruiting. The enrollment target is 80 participants. The study started on 2024-04-19. Estimated completion is 2028-03-25.
What conditions does trial NCT06263023 study?
This clinical trial studies the following conditions: Organ Preservation.
What interventions are being tested in trial NCT06263023?
The interventions under investigation include: Sub-Normothermic Machine Preservation and Assessment (OTHER).
Who is sponsoring clinical trial NCT06263023?
This trial is sponsored by 34 Lives, PBC, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06263023 being conducted?
This trial has 8 study locations across Illinois, Indiana, Missouri, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Organ Preservation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI